Endocrinology and cardiology Symposium

Select the patients that are unlikely to benefit from indefinite anticoagulation

Warfarin is stopped for 5 days before surgery. INR at the time of surgery should be ≥ 1.5 for patients at significant risk of an embolic event

All the below are risk factors for VTE recurrence except:

To determine the need for warfarin hold and bridging, assess the patient’s risk of bleeding like

In making the decision to indefinitely Anticoagulate, one should consider

The risk of thrombosis is high with all of these groups except:

Dimer should be tested during the acute phase of the VTE to help decide on the duration of the Anticoagulation

Which of these statements is incorrect ?

Aspirin can be offered for patients who decline Anticoagulation

The monitoring parameter when starting heparin include:

Counter-regulatory hormones increase glycogenesis and improves insulin sensitivity

Is concomitant bleeding a contraindication to the use of anticoagulant treatment in patients with CVT?

Blood sugar target for perioperative non-cardiac non ICU patients ranges between 6.7 and 8.3 mmol/l

What is the preferred agent in treatment of acute CVT?

Which of this statement is the best answer:

Patients with confirmed SVT within 3 cm of the saphenofemoral junction should be considered for:

F.J. is a 40-year-old male with a history of diabetes mellitus type 2 for 10 years, currently he is on glargine 32 units qpm , insulin Aspart 10 units tid.ac . His latest HgbA1c 1 month ago is 7.1 his self-monitoring glucose record is generally acceptable with no episode of hypoglycemia during the last months.
He is scheduled for cholecystectomy tomorrow morning
F.J. had forgotten what does the anesthetist told him about the day before surgery insulin regimen and came to you for an advice

What is the proposed anticoagulation treatment duration for patient with unprovoked CVT:

Dapagliflozin/Empagliflozin/Canagliflozin exert their effect by blocking sodium glucose co-transporters (SGLTs) type 1 & 2 in intestinal mucosa and kidneys, thus prevent reabsorption of glucose

Which of the following cases doesn’t require thrombophilia screen:

The maximum HbA1c reduction exerted by SGLT2 inhibitors is around:

In the EMPA-REG OUTCOME ClinicalTrial, compared to placebo:

SGLT-2 inhibitors are associated with Hyperglycemic DKA and ketosis

Due to their novel insulin independent mechanism, SGLT2 inhibitors are recommended as initial therapy for the majority of patients with type 2 diabetes

Which statement is correct

In most instances in the hospital setting,insulin is the preferred treatment for glycemic control